The mitotic machinery as a source of genetic instability in cancer

Seminars in Cancer Biology

Volumn 9, Issue 4, 1999, Pages 289-302

  Pihan, German A ^a   Doxsey, Stephen J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Aneuploidy; Chromosome missegregation; Genetic instability; Mitosis

Indexed keywords

ANEUPLOIDY; CARCINOGENESIS; CELL CYCLE; CENTROMERE; CENTROSOME; CHROMOSOME INSERTION; CHROMOSOME SEGREGATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MICROTUBULE; MITOSIS; MITOSIS SPINDLE; ONCOGENE; PHENOTYPE; POLYSOME; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0032872295     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1999.0131     Document Type: Article

References (192)

1. Caspersson T. Uber den chemischen aufbau der strukturen des zellkernes. Scand Arch Physiol. 73:1936;8-15.
2. Riley R, Mahin E, Ross W. Riley RS ME, Ross W,. DNA ploidy and cell cycle analysis, in Clinical Applications of Flow Cytometry. 1993;251-322 Igaku-Shoin, New York.
3. Ross JS. DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis. Oncology (Huntingt). 10:1996;867-890.
4. Shackney SE, Smith CA, Miller BW, Burholt DR, Murtha K, Giles HR, Ketterer DM, Pollice AA. Model for the genetic evolution of human solid tumors. Cancer Res. 49:1989;3344-3354.
5. Sandberg AA. The Chromosomes of Human Cancer and Leukemia. 1990;Elsevier, New York.
6. Mitelman F. Catalog of Chromosomal Aberrations in Cancer. 1988;Alan R Liss, Inc, New York.
7. Riley R. Riley RS, Ross W,. Clinical applications of DNA ploidy and cell cycle analysis, in Clinical Applications of Flow Cytometry. 1993;415-585 Ugaku-Shoin, New York.
8. Danque PO, Chen HB, Patil J, Jagirdar J, Orsatti G, Paronetto F. Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation. Mod Pathol. 6:1993;270-275.
9. Bauer TW, Tubbs RR, Edinger MG, Suit PF, Gephardt GN, Levin HS. A prospective comparison of DNA quantitation by image and flow cytometry. Am J Clin Pathol. 93:1990;322-326.
10. Anastasi J. Interphase cytogenetic analysis in the diagnosis and study of neoplastic disorders. Am J Clin Pathol. 95:1991.
11. Herrington CS, Cooper K, McGee JO. Interphase cytogenetics: analysis of numerical chromosome aberrations in isolated cells. J Pathol. 175:1995;283-295.
12. Wernicke C, Thiel G, Lozanova T, Vogel S, Witkowski R. Numerical aberrations of chromosomes 1, 2 and 7 in astrocytomas studied by interphase cytogenetics. Genes Chromosomes Cancer. 19:1997;6-13.
13. Wolfe KQ, Herrington CS. Interphase cytogenetics and pathology: a tool for diagnosis and research. J Pathol. 181:1997;359-361.
14. Steinbeck RG. Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis. Acta Oncol. 36:1997;3-12.
15. Bulten J, Poddighe PJ, Robben JC, Gemmink JH, de Wilde PC, Hanselaar AG. Interphase cytogenetic analysis of cervical intraepithelial neoplasia (see comments). Am J Pathol. 152:1998;495-503.
16. Murphy DS, Hoare SF, Going JJ, Mallon EE, George WD, Kaye SB, Brown R, Black DM, Keith WN. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst. 87:1995;1694-1704.
17. Visscher DW, Wallis TL, Crissman JD. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer. 77:1996;315-320.
18. Baretton GB, Vogt T, Blasenbreu S, Lohrs U. Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study. Hum Pathol. 25:1994;506-513.
19. Hofstadter F, Delgado R, Jakse G, Judmaier W. Urothelial dysplasia and carcinoma in situ of the bladder. Cancer. 57:1986;356-361.
20. Chanvitan A, Puttawibul P, Casson AG. Flow cytometry in squamous cell esophageal cancer and precancerous lesions. Dis Esophagus. 10:1997;206-210.
21. Teyssier JR, Ferre D. Frequent clonal chromosomal changes in human non-malignant tumors. Int J Cancer. 44:1989;828-832.
22. Namba M, Mihara K, Fushimi K. Immortalization of human cells and its mechanisms. Crit Rev Oncogene. 7:1996;19-31.
23. Li R, Yerganian G, Duesberg P, Kraemer A, Willer A, Rausch C, Hehlmann R. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc Natl Acad Sci USA. 94:1997;14506-14511.
24. Akagi T, Takata H, Yoshino T, Teramoto N, Yano S, Oka T. Immortalization of rat spleen and thymus T cells by human T-cell leukemia virus type I. Acta Med Okayama. 43:1989;143-151.
25. Bischoff FZ, Yim SO, Pathak S, Grant G, Siciliano MJ, Giovanella BC, Strong LC, Tainsky MA. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res. 50:1990;7979-7984.
26. Crompton NE, Sigg M, Jaussi R. Genome lability in radiation-induced transformants of C3H 10T1/2 mouse fibroblasts. Radiat Res. 138:1994.
27. Little JB. Mutagenic and chromosomal events in radiation transformation. Biochimie. 67:1985;405-415.
28. Morgan WF, Day JP, Kaplan MI, McGhee EM, Limoli CL. Genomic instability induced by ionizing radiation. Radiat Res. 146:1996;247-258.
29. Hansemann D. Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung. Arch Pathol Anat Physiol Klin Med. 119:1890;229-326.
30. Boveri T. Zur Frage der Enstehung Maligner Tumoren, Gustav Fisher Verlag, Jena. 1914.
31. Boyland E. The history and future of chemical carcinogenesis. Br Med Bull. 36:1980;5-10.
32. Bialy H. Aneuploidy and cancer: vintage wine in a new bottle? (news). Nat Biotechnol. 16:1998;137-138.
33. Lancet. 1:1988;92-94.
34. Stehelin D, Varmus HE, Bishop JM, Vogt PK. DNA-related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature. 260:1976;170-173.
35. Loeb LA. Cancer cells exhibit a mutator phenotype. Adv Cancer Res. 72:1998;25-56.
36. Jackson AL, Loeb LA. The mutation rate and cancer. Genetics. 148:1998;1483-1490.
37. Feinberg AP, Rainier S, DeBaun MR. Genomic imprinting, DNA methylation, and cancer. J Natl Cancer Inst Monogr. 17:1995;21-26.
38. Squire J, Weksberg R. Genomic imprinting in tumours. Semin Cancer Biol. 7:1996;41-47.
39. Wilkie AO. The molecular basis of genetic dominance. J Med Genet. 31:1994;89-98.
40. Henikoff S. Dosage-dependent modification of position-effect variegation in Drosophila. Bioessays. 18:1996;401-409.
41. Lasko D, Cavenee W, Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet. 25:1991;281-314.
42. Duesberg P, Rausch C, Rasnick D, Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy (In Process Citation). Proc Natl Acad Sci USA. 95:1998;13692-13697.
43. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature. 386:1997;623-627.
44. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 58:1998;3974-3985.
45. Coons SW, Johnson PC. Regional heterogeneity in the DNA content of human gliomas. Cancer. 72:1993;3052-3060.
46. Chang AR, Grignon DJ, Keeney MM, Koster JL, Kirk ME. DNA content in cervical carcinoma: a flow cytometric assessment of DNA heterogeneity. Int J Gynecol Pathol. 13:1994;330-336.
47. Hoshino T. Heterogeneity of tumor cell DNA content. Prog Exp Tumor Res. 27:1984;83-91.
48. Sasaki K, Murakami T, Nakamura M. Intratumoral heterogeneity in DNA ploidy of esophageal squamous cell carcinomas. Cancer. 68:1991;2403-2406.
49. Schvimer M, Lash RH, Katzin WE. Intratumoral heterogeneity of DNA ploidy in breast carcinomas: a flow cytometric assessment of sampling techniques. Cytometry. 22:1995;292-296.
50. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res. 54:1994;3824-3830.
51. Fiegl M, Tueni C, Schenk T, Jakesz R, Gnant M, Reiner A, Rudas M, Pirc-Danoewinata H, Marosi C, Huber H, et al. Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer. 72:1995;51-55.
52. Gebhart E, Trautmann U, Reichardt S, Liehr T. Chromosomal heterogeneity of aneuploid leukemic cell populations detected by conventional karyotyping and by fluorescence in situ hybridization (FISH). Anticancer Res. 13:1993;1857-1862.
53. Anamthawat-Jonsson K, Eyfjord JE, Ogmundsdottir HM, Petursdottir I, Steinarsdottir M. Instability of chromosomes 1, 3, 16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization. Cancer Genet Cytogenet. 88:1996;1-7.
54. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi OP. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol. 145:1994;624-630.
55. Simpson JF, Quan DE, Ho JP, Slovak ML. Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization. Am J Pathol. 149:1996;751-758.
56. Steinbeck RG. Imbalance of morphologically addressed telophases reflects interphase DNA aneuploidy in tumorigenesis. Eur J Histochem. 41:1997;243-254.
57. Steinbeck RG. Chromosome division figures reveal genomic instability in tumorigenesis of human colon mucosa. Br J Cancer. 77:1998;1027-1033.
58. Segers P, Haesen S, Castelain P, Amy JJ, De Sutter P, Van Dam P, Kirsch-Volders M. Study of numerical aberrations of chromosome 1 by fluorescent in situ hybridization and DNA content by densitometric analysis on (pre)-malignant cervical lesions. Histochem J. 27:1995;24-34.
59. Doxsey S. The centrosome - a tiny organelle with big potential (news; comment). Nat Genet. 20:1998;104-106.
60. Bjorkqvist AM, Tammilehto L, Nordling S, Nurminen M, Anttila S, Mattson K, Knuutila S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer. 77:1998;260.
61. Knuutila S, Armengol G, Bjorkqvist AM, el-Rifai W, Larramendy ML, Monni O, Szymanska J. Comparative genomic hybridization study on pooled DNAs from tumors of one clinical-pathological entity. Cancer Genet Cytogenet. 100:1998;25-30.
62. Imreh S, Kost-Alimova M, Kholodnyuk I, Yang Y, Szeles A, Kiss H, Liu Y, Foster K, Zabarovsky E, Stanbridge E, Klein G. Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth. Genes Chromosomes Cancer. 20:1997;224-233.
63. Robertson GP, Furnari FB, Miele ME, Glendening MJ, Welch DR, Fountain JW, Lugo TG, Huang HJ, Cavenee WK. in vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proc Natl Acad Sci USA. 95:1998;9418-9423.
64. Cassimeris L. Factors regulating cytoplasmic microtubule assembly and disassembly. Curr Opin Cell Biol. 1999.
65. Budman DR. New vinca alkaloids and related compounds. Semin Oncol. 19:1992;639-645.
66. Grindey GB. Vinca alkaloids. Curr Opin Oncol. 1:1989;203-205.
67. Rowinsky EK. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med. 48:1997;353-374.
68. Jordan MA, Toso RJ, Thrower D, Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA. 90:1993;9552-9556.
69. Oshimura M, Barrett JC. Chemically-induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer. Environ Mutagen. 8:1986;129-159.
70. Burke D, Gasdaska P, Hartwell L. Dominant effects of tubulin overexpression in Saccharomyces cerevisiae. Mol Cell Biol. 9:1989;1049-1059.
71. Huffaker TC, Thomas JH, Botstein D. Diverse effects of beta-tubulin mutations on microtubule formation and function. J Cell Biol. 106:1988;1997-2010.
72. Chen XP, Yin H, Huffaker TC. The yeast spindle pole body component Spc72p interacts with Stu2p and is required for proper microtubule assembly. J Cell Biol. 141:1998;1169-1179.
73. Heo SJ, Tatebayashi K, Kato J, Ikeda H. The RHC21 gene of budding yeast, a homologue of the fission yeast rad21+@ml04 gene, is essential for chromosome segregation. Mol Gen Genet. 257:1998;149-156.
74. Hoyt MA, Stearns T, Botstein D. Chromosome instability mutants of Saccharomyces cerevisiae that are defective in microtubule-mediated processes. Mol Cell Biol. 10:1990;223-234.
75. Tatebayashi K, Kato J, Ikeda H. Isolation of a Schizosaccharomyces pombe rad21ts mutant that is aberrant in chromosome segregation, microtubule function, DNA repair and sensitive to hydroxyurea: possible involvement of Rad21 in ubiquitin-mediated proteolysis. Genetics. 148:1998;49-57.
76. Beinhauer JD, Hagan IM, Hegemann JH, Fleig U. Mal3, the fission yeast homologue of the human APC-interacting protein EB-1 is required for microtubule integrity and the maintenance of cell form. J Cell Biol. 139:1997;717-728.
77. Basu J, Williams BC, Li Z, Williams EV, Goldberg ML. Depletion of a Drosophila homolog of yeast Sup35p disrupts spindle assembly, chromosome segregation, and cytokinesis during male meiosis. Cell Motil Cytoskeleton. 39:1998;286-302.
78. Andersen SS, Karsenti E. XMAP310: a Xenopus rescue-promoting factor localized to the mitotic spindle. J Cell Biol. 139:1997;975-983.
79. Charrasse S, Schroeder M, Gauthier-Rouviere C, Ango F, Cassimeris L, Gard DL, Larroque C. The TOGp protein is a new human microtubule-associated protein homologous to the Xenopus XMAP215. J Cell Sci. 111:1998;1371-1383.
80. Belmont LD, Mitchison TJ. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell. 84:1996;623-631.
81. Drewes G, Ebneth A, Mandelkow EM. MAPs, MARKs and microtubule dynamics. Trends Biochem Sci. 23:1998;307-311.
82. Maccioni RB, Cambiazo V. Role of microtubule-associated proteins in the control of microtubule assembly. Physiol Rev. 75:1995;835-864.
83. Belmont L, Mitchison T, Deacon HW. Catastrophic revelations about Op18/stathmin. Trends Biochem Sci. 21:1996;197-198.
84. Nylander K, Marklund U, Brattsand G, Gullberg M, Roos G. Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas. Histochem J. 27:1995;155-160.
85. Melhem RF, Strahler JR, Hailat N, Zhu XX, Hanash SM. Involvement of OP18 in cell proliferation. Biochem Biophys Res Commun. 179:1991;1649-1655.
86. Marklund U, Osterman O, Melander H, Bergh A, Gullberg M. The phenotype of a 'Cdc2 kinase target site-deficient' mutant of oncoprotein 18 reveals a role of this protein in cell cycle control. J Biol Chem. 269:1994;30626-30635.
87. Bobinnec Y, Khodjakov A, Mir LM, Rieder CL, Edde B, Bornens M. Centriole disassembly in vivo and its effect on centrosome structure and function in vertebrate cells (In Process Citation). J Cell Biol. 143:1998;1575-1589.
88. Kellogg DR, Moritz M, Alberts BM. The centrosome and cellular organization. Annu Rev Biochem. 63:1994;639-674.
89. Zimmerman W, Sparks C, Doxsey S. Amorphous no longer: the centrosome comes into focus. Curr Opin Cell Biol. 11:1998;122-128.
90. Dictenberg JB, Zimmerman W, Sparks CA, Young A, Vidair C, Zheng Y, Car rington W, Fay FS, Doxsey SJ. Pericentrin and gamma-tubulin form a protein complex and are organized into a novel lattice at the centrosome. J Cell Biol. 141:1998;163-174.
91. Stearns T, Winey M. The cell center at 100. Cell. 91:1997;303-309.
92. Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci USA. 95:1998;2950-2955.
93. Joshi HC. Gamma-tubulin: the hub of cellular microtubule assemblies. Bioessays. 15:1993;637-643.
94. Nakamura M, Masuda H, Horii J, Kuma K, Yokoyama N, Ohba T, Nishitani H, Miyata T, Tanaka M, Nishimoto T. When overexpressed, a novel centrosomal protein, RanBPM, causes ectopic microtubule nucleation similar to gamma-tubulin. J Cell Biol. 143:1998;1041-1052.
95. Ring D, Hubble R, Kirschner M. Mitosis in a cell with multiple centrioles. J Cell Biol. 94:1982;549-556.
96. Wang XJ, Greenhalgh DA, Jiang A, He D, Zhong L, Medina D, Brinkley BR, Roop DR. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis. Oncogene. 17:1998;35-45.
97. Field C, Li R, Oegema K. Cytokinesis in Eukaryotes: A mechanistic comparison. Curr Opin Cell Biol. 11:1999;68-80.
98. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation [see comments]. Nat Genet. 20:1998;189-193.
99. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ, Plowman GD. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. Embo J. 17:1998;3052-3065.
100. Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science. 283:1999;851-854.
101. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. Abnormal centrosome amplification in the absence of p53. Science. 271:1996;1744-1747.
102. Desai A, Mitchison TJ. A new role for motor proteins as couplers to depolymerizing microtubules (comment). J Cell Biol. 128:1995;1-4.
103. Merdes A, Cleveland DW. Pathways of spindle pole formation: different mechanisms; conserved components. J Cell Biol. 138:1997;953-956.
104. Barton NR, Goldstein LS. Going mobile: microtubule motors and chromosome segregation. Proc Natl Acad Sci USA. 93:1996;1735-1742.
105. Hyman AA, Karsenti E. Morphogenetic properties of microtubules and mitotic spindle assembly. Cell. 84:1996;401-410.
106. Vernos I, Karsenti E. Motors involved in spindle assembly and chromosome segregation. Curr Opin Cell Biol. 8:1996;4-9.
107. Whitehead CM, Winkfein RJ, Rattner JB. The relationship of HsEg5 and the actin cytoskeleton to centrosome separation. Cell Motil Cytoskeleton. 35:1996;298-308.
108. Boleti H, Karsenti E, Vernos I. Xklp2, a novel Xenopus centrosomal kinesin-like protein required for centrosome separation during mitosis. Cell. 84:1996;49-59.
109. Dujardin D, Wacker UI, Moreau A, Schroer TA, Rickard JE, De Mey JR. Evidence for a role of CLIP-170 in the establishment of metaphase chromosome alignment. J Cell Biol. 141:1998;849-862.
110. Echeverri CJ, Paschal BM, Vaughan KT, Vallee RB. Molecular characterization of the 50-kD subunit of dynactin reveals function for the complex in chromosome alignment and spindle organization during mitosis. J Cell Biol. 132:1996;617-633.
111. Schaar BT, Chan GK, Maddox P, Salmon ED, Yen TJ. CENP-E function at kinetochores is essential for chromosome alignment. J Cell Biol. 139:1997;1373-1382.
112. Starr DA, Williams BC, Hays TS, Goldberg ML. ZW10 helps recruit dynactin and dynein to the kinetochore. J Cell Biol. 142:1998;763-774.
113. Rieder CL, Salmon ED. The vertebrate cell kinetochore and its roles during mitosis. Trends Cell Biol. 8:1998;310-318.
114. Afshar K, Scholey J, Hawley RS. Identification of the chromosome localization domain of the Drosophila nod kinesin-like protein. J Cell Biol. 131:1995;833-843.
115. Carpenter AT. Distributive segregation: motors in the polar wind? Cell. 64:1991;885-890.
116. Zhang P, Knowles BA, Goldstein LS, Hawley RS. A kinesin-like protein required for distributive chromosome segregation in Drosophila. Cell. 62:1990;1053-1062.
117. Wood KW, Sakowicz R, Goldstein LS, Cleveland DW. CENP-E is a plus end-directed kinetochore motor required for metaphase chromosome alignment. Cell. 91:1997;357-366.
118. Yan RT, Wang SZ. Increased chromokinesin immunoreactivity in retinoblastoma cells. Gene. 189:1997;263-267.
119. Kim W, Tang Y, Okada Y, Torrey TA, Chattopadhyay SK, Pfleiderer M, Falkner FG, Dorner F, Choi W, Hirokawa N, Morse HC 3rd. Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. J Virol. 72:1998;6898-6901.
120. Murray AW. How to compact DNA [comment]. Science. 282:1998;425.
121. Koshland D, Strunnikov A. Mitotic chromosome condensation. Annu Rev Cell Dev Biol. 12:1996;305-333.
122. Vig BK, Rattner JB. Centromere, kinetochore, and cancer. Crit Rev Oncog. 1:1989;343-371.
123. Vig BK, Sternes KL. Centromeres without kinetochore proteins. Another mechanism for origin of aneuploidy in neoplasia. Cancer Genet Cytogenet. 51:1991;269.
124. Gorbsky GJ. Cell cycle checkpoints: arresting progress in mitosis. Bioessays. 19:1997;193-197.
125. Hsieh TS. DNA topoisomerases. Curr Opin Cell Biol. 4:1992;396-400.
126. Yanagida M. Frontier questions about sister chromatid separation in anaphase. Bioessays. 17:1995;519-526.
127. Yanagida M. Fission yeast cut mutations revisited: control of anaphase. Trends Cell Biol. 8:1998;144-149.
128. Holloway SL. Sister chromatid separation in vivo and in vitro. Curr Opin Genet Dev. 5:1995;243-248.
129. Holm C. Coming undone: how to untangle a chromosome. Cell. 77:1994;955-957.
130. Heck MM. Condensins, cohesins, and chromosome architecture: how to make and break a mitotic chromosome [comment]. Cell. 91:1997;5-8.
131. Cimini D, Antoccia A, Tanzarella C, Degrassi F. Topoisomerase II inhibition in mitosis produces numerical and structural chromosomal aberrations in human fibroblasts. Cytogenet Cell Genet. 76:1997;61-67.
132. Hashimoto S, Danks MK, Chatterjee S, Beck WT, Berger NA. A novel point mutation in the 3′ flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents. Oncol Res. 7:1995;21-29.
133. Jessberger R, Frei C, Gasser SM. Chromosome dynamics: the SMC protein family. Curr Opin Genet Dev. 8:1998;254-259.
134. Schmiesing JA, Ball AR Jr, Gregson HC, Alderton JM, Zhou S, Yokomori K. Identification of two distinct human SMC protein complexes involved in mitotic chromosome dynamics. Proc Natl Acad Sci USA. 95:1998;12906-12911.
135. Hirano T. SMC-mediated chromosome mechanics: a conserved scheme from bacteria to vertebrates? Genes Dev. 3:1999;11-19.
136. Hirano T, Kobayashi R, Hirano M. Condensins, chromosome condensation protein complexes containing XCAP-C, XCAP-E and a Xenopus homolog of the Drosophila Barren protein. Cell. 89:1997;511-521.
137. Kimura K, Hirano M, Kobayashi R, Hirano T. Phosphorylation and activation of 13S condensin by Cdc2 in vitro (see comments). Science. 282:1998;487-490.
138. Kimura K, Hirano T. ATP-dependent positive supercoiling of DNA by 13S condensin: a biochemical implication for chromosome condensation. Cell. 90:1997;625-634.
139. Strunnikov AV, Hogan E, Koshland D. SMC2, a Saccharomyces cerevisiae gene essential for chromosome segregation and condensation, defines a subgroup within the SMC family. Genes Dev. 9:1995;587-599.
140. Michaelis C, Ciosk R, Nasmyth K: Cohesins. chromosomal proteins that prevent premature separation of sister chromatids. Cell. 91:1997;35-45.
141. Uhlmann F, Nasmyth K. Cohesion between sister chromatids must be established during DNA replication. Curr Biol. 8:1998;1095-1101.
142. Miyazaki WY, Orr-Weaver TL. Sister-chromatid cohesion in mitosis and meiosis. Annu Rev Genet. 28:1994;167-187.
143. Zhu D, Ma MS, Zhao RZ, Li MY. Centromere spreading and centromeric aberrations in ovarian tumors. Cancer Genet Cytogenet. 80:1995;63-65.
144. Gebhart ER. Patterns of early centromere separation and aneuploidy in human carcinoma cells. Prog Clin Biol Res. 318:1989;129-135.
145. Litmanovitch T, Altaras MM, Dotan A, Avivi L. Asynchronous replication of homologous alpha-satellite DNA loci in man is associated with non-disjunction. Cytogenet Cell Genet. 81:1998;26-35.
146. Wolf DA, Jackson PK. Cell cycle: oiling the gears of anaphase. Curr Biol. 8:1998.
147. King RW, Deshaies RJ, Peters JM, Kirschner MW. How proteolysis drives the cell cycle. Science. 274:1996;1652-1659.
148. Cohen-Fix O, Koshland D. The metaphase-to-anaphase transition: avoiding a mid-life crisis. Curr Opin Cell Biol. 9:1997;800-806.
149. Townsley FM, Ruderman JV. Proteolytic ratchets that control progression through mitosis. Trends Cell Biol. 8:1998;238-244.
150. Glotzer M. Cytokinesis. Curr Biol. 7:1997.
151. Glotzer M. The mechanism and control of cytokinesis. Curr Opin Cell Biol. 9:1997;815-823.
152. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1998;1497-1501.
153. Tatsuka M, Katayama H, Ota T, Tanaka T, Odashima S, Suzuki F, Terada Y. Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res. 58:1998;4811-4816.
154. Schuebel KE, Movilla N, Rosa JL, Bustelo XR. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. Embo J. 17:1998;6608-6621.
155. Fukasawa K, Vande Woude GF. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol. 17:1997;506-518.
156. Muhua L, Adames NR, Murphy MD, Shields CR, Cooper JA. A cytokinesis checkpoint requiring the yeast homologue of an APC- binding protein. Nature. 393:1998;487-491.
157. Nurse P. Universal control mechanism regulating onset of M-phase. Nature. 344:1990;503-508.
158. Yamamoto H, Monden T, Miyoshi H, Izawa H, Ikeda K, Tsujie M, Ohnishi T, Sekimoto M, Tomita N, Monden M. Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells. Int J Oncol. 13:1998;233-239.
159. Tanimoto A, Kao CY, Chang CC, Sasaguri Y, Padmanabhan R. Deregulation of cdc2 gene expression correlates with overexpression of a 110 kDa CCAAT box binding factor in transformed cells. Carcinogenesis. 19:1998;1735-1741.
160. Kallakury BV, Sheehan CE, Ambros RA, Fisher HA, Kaufman RP Jr, Muraca PJ, Ross JS. Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas. J Clin Oncol. 16:1998;1302.
161. Barrette BA, Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Podratz KC, Roche PC. Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc. 72:1997;925-929.
162. Garcia P, Cales C. Endoreplication in megakaryoblastic cell lines is accompanied by sustained expression of G1/S cyclins and downregulation of cdc25C. Oncogene. 13:1996;695-703.
163. Datta NS, Williams JL, Caldwell J, Curry AM, Ashcraft EK, Long MW. Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol Biol Cell. 7:1996;209-223.
164. Zhang Y, Wang Z, Ravid K. The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J Biol Chem. 271:1996;4266.
165. Baroja A, de la Hoz C, Alvarez A, Vielba R, Sarrat R, Arechaga J, de Gandarias JM. Polyploidization and exit from cell cycle as mechanisms of cultured melanoma cell resistance to methotrexate. Life Sci. 62:1998;2275-2282.
166. Yokoe H, Masumi-Fukazawa A, Sunohara M, Tanzawa H, Sato K, Sato T, Fuse A. Induction of polyploidization in the human erythroleukemia cell line (HEL) by protein kinase inhibitor (K252a) and the phorbol-ester TPA. Leuk Lymphoma. 25:1997;333-343.
167. Secchiero P, Bertolaso L, Casareto L, Gibellini D, Vitale M, Bemis K, Aleotti A, Capitani S, Franchini G, Gallo RC, Zauli G. Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(+) T cells. Blood. 92:1998;1685-1696.
168. Hershko A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol. 9:1997;788-799.
169. Visintin R, Prinz S, Amon A. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science. 278:1997;460-463.
170. al-Khodairy F, Enoch T, Hagan IM, Carr AM. The Schizosaccharomyces pombe hus5 gene encodes a ubiquitin conjugating enzyme required for normal mitosis. J Cell Sci. 108:1995;475-486.
171. Arvand A, Bastians H, Welford SM, Thompson AD, Ruderman JV, Denny CT. EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene. 17:1998;2039-2045.
172. Zhao N, Lai F, Fernald AA, Eisenbart JD, Espinosa R, Wang PW, Le Beau MM. Human CDC23: cDNA cloning, mapping to 5q31, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias. Genomics. 53:1998;184-190.
173. Yang SS, Yeh E, Salmon ED, Bloom K. Identification of a mid-anaphase checkpoint in budding yeast. J Cell Biol. 136:1997;345-354.
174. Hardwick KG. The spindle checkpoint. Trends Genet. 14:1998;1-4.
175. Gorbsky GJ, Chen RH, Murray AW. Microinjection of antibody to Mad2 protein into mammalian cells in mitosis induces premature anaphase. J Cell Biol. 141:1998;1193-1205.
176. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Mutations of mitotic checkpoint genes in human cancers (see comments). Nature. 392:1998;300-303.
177. Jansen-Durr P. How viral oncogenes make the cell cycle. Trends Genet. 12:1996;270-275.
178. Vousden KH. Regulation of the cell cycle by viral oncoproteins. Semin Cancer Biol. 6:1995;109-116.
179. Jin DY, Spencer F, Jeang KT. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell. 93:1998;81-91.
180. Chang TH, Ray FA, Thompson DA, Schlegel R. Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells. Oncogene. 14:1997;2383.
181. Thomas JT, Laimins LA. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J Virol. 72:1998;1131-1137.
182. Thompson DA, Belinsky G, Chang TH, Jones DL, Schlegel R, Munger K. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene. 15:1997;3025-3035.
183. Frattini MG, Hurst SD, Lim HB, Swaminathan S, Laimins LA. Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. Embo J. 16:1997;318-331.
184. Knecht H, McQuain C, Martin J, Rothenberger S, Drexler HG, Berger C, Bachmann E, Kittler EL, Odermatt BF, Quesenberry PJ. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Oncogene. 13:1996;947-953.
185. O'Neill FJ. Control of nuclear division in sv40 and adenovirus type 12 transformed mouse 3t3 cells. Int J Cancer. 15:1975;715-723.
186. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 396:1998;580-584.
187. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA. 93:1996;4974-4978.
188. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 3:1997;917-921.
189. Sorger PK, Dobles M, Tournebize R, Hyman AA. Coupling cell division and cell death to microtubule dynamics. Curr Opin Cell Biol. 9:1997;807-814.
190. Woods CM, Zhu J, McQueney PA, Bollag D, Lazarides E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med. 1:1995;506-526.
191. Taylor SS, McKeon F. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell. 89:1997;727-735.
192. Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res. 57:1997;229-233.